Carbohydrate Antigen 19-9 eCLIA is an immunoassay reagent for in vitro quantitative determination of Carbohydrate Antigen 19-9 (CA19-9) in human serum or plasma by fully automated immunoassay analyzer monitor the therapeutic effect of pancreatic and other digestive tract malignant tumors.
